The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure
The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure
The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>NT</strong>-<strong>pro<strong>BNP</strong></strong> Concentrations<br />
B<strong>as</strong>eline Follow-up P<br />
Overall 2118 1321 .02<br />
By treatment allocation<br />
Treatment B<strong>as</strong>eline Follow-up P<br />
SOC 1946 1844 .61<br />
<strong>NT</strong>-<strong>pro<strong>BNP</strong></strong> 2344 1125 .01<br />
P = .03 for SOC follow-up versus <strong>NT</strong>-<strong>pro<strong>BNP</strong></strong> follow-up<br />
44.3% <strong>of</strong> <strong>NT</strong>-<strong>pro<strong>BNP</strong></strong> subjects 1000 pg/mL<br />
Source: Januzzi et al. clinicaltrialresults.org/Slides/PROTECT%20Presentation%20FINAL.ppt, accessed March 27, 2012<br />
28
Change language